The company's principal activity is to develop and market a commercially viable hypodermic syringe that reduces the risk of accidental needle injuries. The syringe uses a proprietary and patented technology whereby a vacuum causes the needle to retract into the barrel of the syringe after an injection is given. The company is in the development stage and also plans to develop a prototype of a blood extraction device. The company will target clinics, hospitals, doctors' office, laboratories, public health departments, medical research facilities, medical schools and retail purchaser of syringes for diabetes to market the syringe.
